# Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

> **NCT00931320** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 3000 (estimated)

## Conditions studied

- Dyslipidemias

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00931320
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** —
- **Final completion:** 2009-09
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2009-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931320, "Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00931320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*